<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2017-12-20" version="189">
<accession>P00915</accession>
<name>CAH1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Carbonic anhydrase 1</fullName>
<ecNumber>4.2.1.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Carbonate dehydratase I</fullName>
</alternativeName>
<alternativeName>
<fullName>Carbonic anhydrase B</fullName>
<shortName>CAB</shortName>
</alternativeName>
<alternativeName>
<fullName>Carbonic anhydrase I</fullName>
<shortName>CA-I</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">CA1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Nucleic Acids Res." volume="15" first="2386" last="2386">
<title>Human carbonic anhydrase I cDNA.</title>
<authorList>
<person name="Barlow J.H."/>
<person name="Lowe N."/>
<person name="Edwards Y.H."/>
<person name="Butterworth P.H.W."/>
</authorList>
<dbReference type="PubMed" id="3104879"/>
<dbReference type="DOI" id="10.1093/nar/15.5.2386"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="Gene" volume="93" first="277" last="283">
<title>Structure and methylation patterns of the gene encoding human carbonic anhydrase I.</title>
<authorList>
<person name="Lowe N."/>
<person name="Brady H.J.M."/>
<person name="Barlow J.H."/>
<person name="Sowden J.C."/>
<person name="Edwards M."/>
<person name="Butterworth P.H.W."/>
</authorList>
<dbReference type="PubMed" id="2121614"/>
<dbReference type="DOI" id="10.1016/0378-1119(90)90236-K"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pancreas</tissue>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1974" name="Biochimie" volume="56" first="1031" last="1043">
<title>Primary structure of human B erythrocyte carbonic anhydrase. 3. Sequence of CNBr fragment I and III (residues 149-260).</title>
<authorList>
<person name="Giraud N."/>
<person name="Marriq C."/>
<person name="Laurent-Tabusse G."/>
</authorList>
<dbReference type="PubMed" id="4217196"/>
<dbReference type="DOI" id="10.1016/S0300-9084(74)80093-3"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-261</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1972" name="Biochem. Biophys. Res. Commun." volume="48" first="670" last="677">
<title>Amino acid sequence of human erythrocyte carbonic anhydrase B.</title>
<authorList>
<person name="Andersson B."/>
<person name="Nyman P.O."/>
<person name="Strid L."/>
</authorList>
<dbReference type="PubMed" id="4625868"/>
<dbReference type="DOI" id="10.1016/0006-291X(72)90400-7"/>
</citation>
<scope>PROTEIN SEQUENCE OF 20-261</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1973" name="J. Biol. Chem." volume="248" first="1885" last="1893">
<title>Human carbonic anhydrases. XI. The complete primary structure of carbonic anhydrase B.</title>
<authorList>
<person name="Lin K.-T.D."/>
<person name="Deutsch H.F."/>
</authorList>
<dbReference type="PubMed" id="4632246"/>
</citation>
<scope>PROTEIN SEQUENCE OF 12-261</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1974" name="J. Biol. Chem." volume="249" first="2329" last="2337">
<title>Human carbonic anhydrases. XII. The complete primary structure of the C isozyme.</title>
<authorList>
<person name="Lin K.-T.D."/>
<person name="Deutsch H.F."/>
</authorList>
<dbReference type="PubMed" id="4207120"/>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="J. Biol. Inorg. Chem." volume="4" first="528" last="536">
<title>Carbonic anhydrase catalyzes cyanamide hydration to urea: is it mimicking the physiological reaction?</title>
<authorList>
<person name="Briganti F."/>
<person name="Mangani S."/>
<person name="Scozzafava A."/>
<person name="Vernaglione G."/>
<person name="Supuran C.T."/>
</authorList>
<dbReference type="PubMed" id="10550681"/>
<dbReference type="DOI" id="10.1007/s007750050375"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Chemistry" volume="12" first="7057" last="7066">
<title>Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.</title>
<authorList>
<person name="Temperini C."/>
<person name="Scozzafava A."/>
<person name="Vullo D."/>
<person name="Supuran C.T."/>
</authorList>
<dbReference type="PubMed" id="16807956"/>
<dbReference type="DOI" id="10.1002/chem.200600159"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="J. Med. Chem." volume="49" first="3019" last="3027">
<title>Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design.</title>
<authorList>
<person name="Temperini C."/>
<person name="Scozzafava A."/>
<person name="Vullo D."/>
<person name="Supuran C.T."/>
</authorList>
<dbReference type="PubMed" id="16686544"/>
<dbReference type="DOI" id="10.1021/jm0603320"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Bioorg. Med. Chem. Lett." volume="17" first="628" last="635">
<title>Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV.</title>
<authorList>
<person name="Temperini C."/>
<person name="Innocenti A."/>
<person name="Scozzafava A."/>
<person name="Mastrolorenzo A."/>
<person name="Supuran C.T."/>
</authorList>
<dbReference type="PubMed" id="17127057"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2006.11.027"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Bioorg. Med. Chem. Lett." volume="19" first="1371" last="1375">
<title>A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases.</title>
<authorList>
<person name="Crocetti L."/>
<person name="Maresca A."/>
<person name="Temperini C."/>
<person name="Hall R.A."/>
<person name="Scozzafava A."/>
<person name="Muehlschlegel F.A."/>
<person name="Supuran C.T."/>
</authorList>
<dbReference type="PubMed" id="19186056"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2009.01.038"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="J. Am. Chem. Soc." volume="131" first="3057" last="3062">
<title>Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors.</title>
<authorList>
<person name="Maresca A."/>
<person name="Temperini C."/>
<person name="Vu H."/>
<person name="Pham N.B."/>
<person name="Poulsen S.-A."/>
<person name="Scozzafava A."/>
<person name="Quinn R.J."/>
<person name="Supuran C.T."/>
</authorList>
<dbReference type="PubMed" id="19206230"/>
<dbReference type="DOI" id="10.1021/ja809683v"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Proteins" volume="74" first="164" last="175">
<title>Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.</title>
<authorList>
<person name="Di Fiore A."/>
<person name="Monti S.M."/>
<person name="Hilvo M."/>
<person name="Parkkila S."/>
<person name="Romano V."/>
<person name="Scaloni A."/>
<person name="Pedone C."/>
<person name="Scozzafava A."/>
<person name="Supuran C.T."/>
<person name="De Simone G."/>
</authorList>
<dbReference type="PubMed" id="18618712"/>
<dbReference type="DOI" id="10.1002/prot.22144"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="1972" name="J. Mol. Biol." volume="63" first="601" last="604">
<title>Structure of human carbonic anhydrase B. I. Crystallization and heavy atom modifications.</title>
<authorList>
<person name="Kannan K.K."/>
<person name="Fridborg K."/>
<person name="Bergsten P.C."/>
<person name="Liljas A."/>
<person name="Loevgren S."/>
<person name="Petef M."/>
<person name="Strandberg B."/>
<person name="Waara I."/>
<person name="Adler L."/>
<person name="Falkbring S.O."/>
<person name="Goethe P.O."/>
<person name="Nyman P.O."/>
</authorList>
<dbReference type="PubMed" id="4622589"/>
<dbReference type="DOI" id="10.1016/0022-2836(72)90452-4"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-260</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1975" name="Proc. Natl. Acad. Sci. U.S.A." volume="72" first="51" last="55">
<title>Crystal structure of human erythrocyte carbonic anhydrase B. Three-dimensional structure at a nominal 2.2-A resolution.</title>
<authorList>
<person name="Kannan K.K."/>
<person name="Notstrand B."/>
<person name="Fridborg K."/>
<person name="Loevgren S."/>
<person name="Ohlsson A."/>
<person name="Petef M."/>
</authorList>
<dbReference type="PubMed" id="804171"/>
<dbReference type="DOI" id="10.1073/pnas.72.1.51"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS)</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1984" name="Ann. N. Y. Acad. Sci." volume="429" first="49" last="60">
<title>Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I.</title>
<authorList>
<person name="Kannan K.K."/>
<person name="Ramanadham M."/>
<person name="Jones T.A."/>
</authorList>
<dbReference type="PubMed" id="6430186"/>
<dbReference type="DOI" id="10.1111/j.1749-6632.1984.tb12314.x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-260 IN COMPLEX WITH ZINC ION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1994" name="Acta Crystallogr. D" volume="50" first="731" last="738">
<title>Differences in anionic inhibition of human carbonic anhydrase I revealed from the structures of iodide and gold cyanide inhibitor complexes.</title>
<authorList>
<person name="Kumar V."/>
<person name="Kannan K.K."/>
<person name="Sathyamurthi P."/>
</authorList>
<dbReference type="PubMed" id="15299369"/>
<dbReference type="DOI" id="10.1107/S0907444994001873"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-260 IN COMPLEX WITH ZINC ION AND INHIBITORS</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1994" name="J. Mol. Biol." volume="241" first="226" last="232">
<title>Enzyme-substrate interactions. Structure of human carbonic anhydrase I complexed with bicarbonate.</title>
<authorList>
<person name="Kumar V."/>
<person name="Kannan K.K."/>
</authorList>
<dbReference type="PubMed" id="8057362"/>
<dbReference type="DOI" id="10.1006/jmbi.1994.1491"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 2-260 IN COMPLEX WITH ZINC ION AND BICARBONATE</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1994" name="J. Mol. Biol." volume="243" first="298" last="309">
<title>Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.</title>
<authorList>
<person name="Chakravarty S."/>
<person name="Kannan K.K."/>
</authorList>
<dbReference type="PubMed" id="7932756"/>
<dbReference type="DOI" id="10.1006/jmbi.1994.1655"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-260 IN COMPLEX WITH ZINC ION AND INHIBITORS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Biochemistry" volume="41" first="6237" last="6244">
<title>Crystal structure of a zinc-activated variant of human carbonic anhydrase I, CA I Michigan 1: evidence for a second zinc binding site involving arginine coordination.</title>
<authorList>
<person name="Ferraroni M."/>
<person name="Tilli S."/>
<person name="Briganti F."/>
<person name="Chegwidden W.R."/>
<person name="Supuran C.T."/>
<person name="Wiebauer K.E."/>
<person name="Tashian R.E."/>
<person name="Scozzafava A."/>
</authorList>
<dbReference type="PubMed" id="12009884"/>
<dbReference type="DOI" id="10.1021/bi0120446"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-260 IN COMPLEX WITH ZINC ION</scope>
<scope>VARIANT MICHIGAN-1 ARG-68</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Bioorg. Med. Chem. Lett." volume="16" first="5152" last="5156">
<title>Carbonic anhydrase activators: the first X-ray crystallographic study of an adduct of isoform I.</title>
<authorList>
<person name="Temperini C."/>
<person name="Scozzafava A."/>
<person name="Supuran C.T."/>
</authorList>
<dbReference type="PubMed" id="16870440"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2006.07.021"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-260 IN COMPLEX WITH ZINC ION AND ACTIVATORS</scope>
<scope>ACTIVATION BY IMIDAZOLE AND HISTIDINE</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="J. Am. Chem. Soc." volume="128" first="3011" last="3018">
<title>Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with 'two-prong' inhibitors reveal the molecular basis of high affinity.</title>
<authorList>
<person name="Jude K.M."/>
<person name="Banerjee A.L."/>
<person name="Haldar M.K."/>
<person name="Manokaran S."/>
<person name="Roy B."/>
<person name="Mallik S."/>
<person name="Srivastava D.K."/>
<person name="Christianson D.W."/>
</authorList>
<dbReference type="PubMed" id="16506782"/>
<dbReference type="DOI" id="10.1021/ja057257n"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 2-260 IN COMPLEX WITH ZINC ION AND INHIBITORS</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Bioorg. Med. Chem. Lett." volume="17" first="2210" last="2215">
<title>Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I.</title>
<authorList>
<person name="Temperini C."/>
<person name="Innocenti A."/>
<person name="Guerri A."/>
<person name="Scozzafava A."/>
<person name="Rusconi S."/>
<person name="Supuran C.T."/>
</authorList>
<dbReference type="PubMed" id="17314045"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2007.01.113"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 6-260 IN COMPLEX WITH ZINC ION AND THE ANTIVIRAL FOSCARNET</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Am. Chem. Soc." volume="129" first="5528" last="5537">
<title>Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II.</title>
<authorList>
<person name="Srivastava D.K."/>
<person name="Jude K.M."/>
<person name="Banerjee A.L."/>
<person name="Haldar M."/>
<person name="Manokaran S."/>
<person name="Kooren J."/>
<person name="Mallik S."/>
<person name="Christianson D.W."/>
</authorList>
<dbReference type="PubMed" id="17407288"/>
<dbReference type="DOI" id="10.1021/ja068359w"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 2-260 IN COMPLEX WITH ZINC ION AND INHIBITORS</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1981" name="Am. J. Hum. Genet." volume="33" first="105" last="111">
<title>Population genetic studies of the Philippine Negritos. III. Identification of the carbonic anhydrase-1 variant with CA1 Guam.</title>
<authorList>
<person name="Omoto K."/>
<person name="Ueda S."/>
<person name="Goriki K."/>
<person name="Takahashi N."/>
<person name="Misawa S."/>
<person name="Pagaran I.G."/>
</authorList>
<dbReference type="PubMed" id="6781336"/>
</citation>
<scope>VARIANT GUAM ARG-254</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1994" name="Hum. Mutat." volume="4" first="294" last="296">
<title>Marked zinc activation of ester hydrolysis by a mutation, 67-His (CAT) to Arg (CGT), in the active site of human carbonic anhydrase I.</title>
<authorList>
<person name="Chegwidden W.R."/>
<person name="Wagner L.E."/>
<person name="Venta P.J."/>
<person name="Bergenhem N.C.H."/>
<person name="Yu Y.-S.L."/>
<person name="Tashian R.E."/>
</authorList>
<dbReference type="PubMed" id="7866410"/>
<dbReference type="DOI" id="10.1002/humu.1380040411"/>
</citation>
<scope>VARIANT MICHIGAN-1 ARG-68</scope>
</reference>
<comment type="function">
<text evidence="6">Reversible hydration of carbon dioxide. Can hydrates cyanamide to urea.</text>
</comment>
<comment type="catalytic activity">
<text>H(2)CO(3) = CO(2) + H(2)O.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="7 8 9 12 14 15 21 24 25 26">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="9 10 11 13 14 15 16 17 18">Activated by histamine, imidazole, L-adrenaline, L- and D-histidine, and L- and D-phenylalanine. Inhibited by coumarins, sulfonamide derivatives such as acetazolamide, benzenesulfonamide and derivatives (4-carboxyethylbenzene-sulfonamide, 4-carboxyethylbenzene-sulfonamide ethyl ester, 4-(acetyl-2-aminoethyl)benzene-sulfonamide, 4-aminoethylbenzene-sulfonamide), and 'prong inhibitors' BR15, BR17, BR22 and BR30. Activated by a short exposition to Foscarnet (phosphonoformate trisodium salt), but inhibited by a long one. Esterase activity weakly reduced by cyanamide.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="6 16">4.0 mM for CO(2)</KM>
<KM evidence="6 16">15 mM for 4-nitrophenyl acetate</KM>
</kinetics>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3912102"/>
<interactant intactId="EBI-717422">
<id>Q12800</id>
<label>TFCP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the alpha-carbonic anhydrase family.</text>
</comment>
<dbReference type="EC" id="4.2.1.1"/>
<dbReference type="EMBL" id="X05014">
<property type="protein sequence ID" value="CAA28663.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M33987">
<property type="protein sequence ID" value="AAA51910.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC027890">
<property type="protein sequence ID" value="AAH27890.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6237.1"/>
<dbReference type="PIR" id="JQ0786">
<property type="entry name" value="CRHU1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001122301.1">
<property type="nucleotide sequence ID" value="NM_001128829.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001122302.1">
<property type="nucleotide sequence ID" value="NM_001128830.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001122303.1">
<property type="nucleotide sequence ID" value="NM_001128831.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001158302.1">
<property type="nucleotide sequence ID" value="NM_001164830.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001729.1">
<property type="nucleotide sequence ID" value="NM_001738.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.23118"/>
<dbReference type="PDB" id="1AZM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-261"/>
</dbReference>
<dbReference type="PDB" id="1BZM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-261"/>
</dbReference>
<dbReference type="PDB" id="1CRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-261"/>
</dbReference>
<dbReference type="PDB" id="1CZM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-261"/>
</dbReference>
<dbReference type="PDB" id="1HCB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=2-261"/>
</dbReference>
<dbReference type="PDB" id="1HUG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-261"/>
</dbReference>
<dbReference type="PDB" id="1HUH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2-261"/>
</dbReference>
<dbReference type="PDB" id="1J9W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="1JV0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="2CAB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-261"/>
</dbReference>
<dbReference type="PDB" id="2FOY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="2FW4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="2IT4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=6-261"/>
</dbReference>
<dbReference type="PDB" id="2NMX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="2NN1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="2NN7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="3LXE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="3W6H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="A/B=2-261"/>
</dbReference>
<dbReference type="PDB" id="3W6I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.69"/>
<property type="chains" value="A/E=2-261"/>
</dbReference>
<dbReference type="PDB" id="4WR7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B=3-261"/>
</dbReference>
<dbReference type="PDB" id="4WUP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=3-261"/>
</dbReference>
<dbReference type="PDB" id="4WUQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=3-261"/>
</dbReference>
<dbReference type="PDB" id="5E2M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.41"/>
<property type="chains" value="A/B=3-261"/>
</dbReference>
<dbReference type="PDB" id="5GMM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1-261"/>
</dbReference>
<dbReference type="PDBsum" id="1AZM"/>
<dbReference type="PDBsum" id="1BZM"/>
<dbReference type="PDBsum" id="1CRM"/>
<dbReference type="PDBsum" id="1CZM"/>
<dbReference type="PDBsum" id="1HCB"/>
<dbReference type="PDBsum" id="1HUG"/>
<dbReference type="PDBsum" id="1HUH"/>
<dbReference type="PDBsum" id="1J9W"/>
<dbReference type="PDBsum" id="1JV0"/>
<dbReference type="PDBsum" id="2CAB"/>
<dbReference type="PDBsum" id="2FOY"/>
<dbReference type="PDBsum" id="2FW4"/>
<dbReference type="PDBsum" id="2IT4"/>
<dbReference type="PDBsum" id="2NMX"/>
<dbReference type="PDBsum" id="2NN1"/>
<dbReference type="PDBsum" id="2NN7"/>
<dbReference type="PDBsum" id="3LXE"/>
<dbReference type="PDBsum" id="3W6H"/>
<dbReference type="PDBsum" id="3W6I"/>
<dbReference type="PDBsum" id="4WR7"/>
<dbReference type="PDBsum" id="4WUP"/>
<dbReference type="PDBsum" id="4WUQ"/>
<dbReference type="PDBsum" id="5E2M"/>
<dbReference type="PDBsum" id="5GMM"/>
<dbReference type="ProteinModelPortal" id="P00915"/>
<dbReference type="SMR" id="P00915"/>
<dbReference type="BioGrid" id="107214">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="IntAct" id="P00915">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000256119"/>
<dbReference type="BindingDB" id="P00915"/>
<dbReference type="ChEMBL" id="CHEMBL261"/>
<dbReference type="DrugBank" id="DB08156">
<property type="generic name" value="3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID"/>
</dbReference>
<dbReference type="DrugBank" id="DB00819">
<property type="generic name" value="Acetazolamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00381">
<property type="generic name" value="Amlodipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00436">
<property type="generic name" value="Bendroflumethiazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00562">
<property type="generic name" value="Benzthiazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01194">
<property type="generic name" value="Brinzolamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00880">
<property type="generic name" value="Chlorothiazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00606">
<property type="generic name" value="Cyclothiazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01119">
<property type="generic name" value="Diazoxide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01144">
<property type="generic name" value="Diclofenamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00869">
<property type="generic name" value="Dorzolamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB08846">
<property type="generic name" value="Ellagic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01031">
<property type="generic name" value="Ethinamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00311">
<property type="generic name" value="Ethoxzolamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB08157">
<property type="generic name" value="ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE"/>
</dbReference>
<dbReference type="DrugBank" id="DB00999">
<property type="generic name" value="Hydrochlorothiazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00774">
<property type="generic name" value="Hydroflumethiazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00703">
<property type="generic name" value="Methazolamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00423">
<property type="generic name" value="Methocarbamol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00232">
<property type="generic name" value="Methyclothiazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB08155">
<property type="generic name" value="N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB01325">
<property type="generic name" value="Quinethazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09460">
<property type="generic name" value="Sodium carbonate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01021">
<property type="generic name" value="Trichlormethiazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00909">
<property type="generic name" value="Zonisamide"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2597"/>
<dbReference type="iPTMnet" id="P00915"/>
<dbReference type="PhosphoSitePlus" id="P00915"/>
<dbReference type="BioMuta" id="CA1"/>
<dbReference type="DMDM" id="115449"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P00915"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00215983"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P00915"/>
<dbReference type="UCD-2DPAGE" id="P00915"/>
<dbReference type="PaxDb" id="P00915"/>
<dbReference type="PeptideAtlas" id="P00915"/>
<dbReference type="PRIDE" id="P00915"/>
<dbReference type="TopDownProteomics" id="P00915"/>
<dbReference type="DNASU" id="759"/>
<dbReference type="Ensembl" id="ENST00000431316">
<property type="protein sequence ID" value="ENSP00000392338"/>
<property type="gene ID" value="ENSG00000133742"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000523022">
<property type="protein sequence ID" value="ENSP00000429798"/>
<property type="gene ID" value="ENSG00000133742"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000523953">
<property type="protein sequence ID" value="ENSP00000430656"/>
<property type="gene ID" value="ENSG00000133742"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000542576">
<property type="protein sequence ID" value="ENSP00000443517"/>
<property type="gene ID" value="ENSG00000133742"/>
</dbReference>
<dbReference type="GeneID" id="759"/>
<dbReference type="KEGG" id="hsa:759"/>
<dbReference type="CTD" id="759"/>
<dbReference type="DisGeNET" id="759"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000133742.13"/>
<dbReference type="GeneCards" id="CA1"/>
<dbReference type="HGNC" id="HGNC:1368">
<property type="gene designation" value="CA1"/>
</dbReference>
<dbReference type="HPA" id="CAB025790"/>
<dbReference type="HPA" id="HPA006558"/>
<dbReference type="MIM" id="114800">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P00915"/>
<dbReference type="OpenTargets" id="ENSG00000133742"/>
<dbReference type="PharmGKB" id="PA25984"/>
<dbReference type="eggNOG" id="KOG0382">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG3338">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118915"/>
<dbReference type="HOGENOM" id="HOG000112637"/>
<dbReference type="HOVERGEN" id="HBG002837"/>
<dbReference type="InParanoid" id="P00915"/>
<dbReference type="KO" id="K01672"/>
<dbReference type="OMA" id="VTWIICK"/>
<dbReference type="OrthoDB" id="EOG091G0XFM"/>
<dbReference type="PhylomeDB" id="P00915"/>
<dbReference type="TreeFam" id="TF316425"/>
<dbReference type="BRENDA" id="4.2.1.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1237044">
<property type="pathway name" value="Erythrocytes take up carbon dioxide and release oxygen"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1247673">
<property type="pathway name" value="Erythrocytes take up oxygen and release carbon dioxide"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1475029">
<property type="pathway name" value="Reversible hydration of carbon dioxide"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8950505">
<property type="pathway name" value="Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation"/>
</dbReference>
<dbReference type="SABIO-RK" id="P00915"/>
<dbReference type="EvolutionaryTrace" id="P00915"/>
<dbReference type="GeneWiki" id="CA1_(gene)"/>
<dbReference type="GenomeRNAi" id="759"/>
<dbReference type="PRO" id="PR:P00915"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000133742"/>
<dbReference type="CleanEx" id="HS_CA1"/>
<dbReference type="ExpressionAtlas" id="P00915">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P00915">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004064">
<property type="term" value="F:arylesterase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0004089">
<property type="term" value="F:carbonate dehydratase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0016836">
<property type="term" value="F:hydro-lyase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0015701">
<property type="term" value="P:bicarbonate transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035722">
<property type="term" value="P:interleukin-12-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006730">
<property type="term" value="P:one-carbon metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.10.200.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001148">
<property type="entry name" value="Carbonic_anhydrase_a"/>
</dbReference>
<dbReference type="InterPro" id="IPR023561">
<property type="entry name" value="Carbonic_anhydrase_a-class"/>
</dbReference>
<dbReference type="InterPro" id="IPR018338">
<property type="entry name" value="Carbonic_anhydrase_a-class_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR036398">
<property type="entry name" value="Carbonic_anhydrase_a_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018442">
<property type="entry name" value="Carbonic_anhydrase_CA1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR18952">
<property type="entry name" value="PTHR18952"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR18952:SF82">
<property type="entry name" value="PTHR18952:SF82"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00194">
<property type="entry name" value="Carb_anhydrase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01057">
<property type="entry name" value="Carb_anhydrase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51069">
<property type="entry name" value="SSF51069"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00162">
<property type="entry name" value="ALPHA_CA_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51144">
<property type="entry name" value="ALPHA_CA_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0456">Lyase</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="initiator methionine" description="Removed" evidence="20">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Carbonic anhydrase 1" id="PRO_0000077409">
<location>
<begin position="2"/>
<end position="261"/>
</location>
</feature>
<feature type="domain" description="Alpha-carbonic anhydrase" evidence="5">
<location>
<begin position="4"/>
<end position="261"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="4">
<location>
<begin position="200"/>
<end position="201"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="5">
<location>
<position position="65"/>
</location>
</feature>
<feature type="active site" evidence="4">
<location>
<position position="129"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2; in variant Michigan-1" evidence="7">
<location>
<position position="65"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2; in variant Michigan-1" evidence="7">
<location>
<position position="68"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; catalytic" evidence="7 8 9 12 14 15 21 24 25 26">
<location>
<position position="95"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; catalytic" evidence="7 8 9 12 14 15 21 24 25 26">
<location>
<position position="97"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; catalytic" evidence="7 8 9 12 14 15 21 24 25 26">
<location>
<position position="120"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2; in variant Michigan-1" evidence="7">
<location>
<position position="201"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="26">
<location>
<position position="200"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="19 20">
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In variant Michigan-1; confers enhanced esterase activity and an additional zinc binding site; dbSNP:rs990757234." id="VAR_001378" evidence="7 23">
<original>H</original>
<variation>R</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7821248." id="VAR_048679">
<original>A</original>
<variation>V</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In Guam; dbSNP:rs121909577." id="VAR_001379" evidence="22">
<original>G</original>
<variation>R</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AA sequence and 5; AA sequence." ref="4 5" evidence="27">
<original>DN</original>
<variation>ND</variation>
<location>
<begin position="75"/>
<end position="76"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="10"/>
<end position="12"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="14"/>
<end position="19"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="22"/>
<end position="25"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="26"/>
<end position="28"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="32"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="36"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="48"/>
<end position="51"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="54"/>
<end position="56"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="57"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="67"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="74"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="89"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="100"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="107"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="116"/>
<end position="125"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="126"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="132"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="141"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="156"/>
<end position="158"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="159"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="165"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="182"/>
<end position="185"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="192"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="208"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="221"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="230"/>
<end position="233"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1HCB"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1J9W"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E2M"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01134"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10550681"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12009884"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15299369"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16506782"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16686544"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16807956"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16870440"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17127057"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17314045"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17407288"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18618712"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19186056"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19206230"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="4207120"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="4217196"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6430186"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6781336"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7866410"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7932756"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="804171"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8057362"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="261" mass="28870" checksum="4959E5FA25E374F8" modified="2007-01-23" version="2">
MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEI
INVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELH
VAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNF
DPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAV
PMQHNNRPTQPLKGRTVRASF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>